CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels. Bai Y, Liu Y, Wu J, Miao R, et al. J Cancer Res Clin Oncol 2023;149:16827-16836.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bai Y, Liu Y, Wu J, Miao R, et al. CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels. J Cancer Res Clin Oncol 2023;149:16827-16836.
PMID: 37733240